STOCK · PG · NYSE
Procter & Gamble Company (The) trades under the ticker symbol PG on the NYSE. This page brings together its live stock price, an interactive price chart, and key fundamentals like market capitalization, 52-week range, dividend yield, and the next earnings date, with plain-English context to help you understand what the numbers mean.
Loading the live price and chart for PG…
Stock prices move on company earnings, growth expectations, interest rates, and overall market sentiment. Use the live chart and fundamentals as a starting point for your own research, never as a buy or sell signal.
Procter & Gamble sells everyday products: Tide detergent, Pampers diapers, Gillette razors, Oral-B toothbrushes, Pantene shampoo. These are things people buy regardless of economic conditions, which makes P&G one of the most stable large companies in the S&P 500.
P&G operates in over 180 countries and has pricing power that most consumer brands lack. When input costs rise, P&G has historically passed increases through to consumers without losing significant market share, because people tend to stick with trusted brands for daily necessities.
65 consecutive years of dividend increases put P&G in a very small group of Dividend Kings. The payout grows slowly but reliably, and that consistency is part of why institutional investors and retirees hold it as a core position.
Source: Procter & Gamble SEC filings (10-K) and investor relations · Last reviewed June 2026
Procter & Gamble Company (The) scores 72 out of 100 (grade B) across the 4 measures we can read from its filings. Its strongest measure is profitability (grade A); its weakest is growth (grade C).
Rule-based grades derived from annual figures reported to the SEC. Descriptive, not a rating of the investment.
Procter & Gamble grew its revenue slowly (about 2.9% a year) over the 9 years through FY2025, and profit grew about in step with sales. Its profit margin held roughly steady. Free cash flow grew alongside profit.
Steady. Revenue went from $65.3B in FY2016 to $84.3B in FY2025, about 2.9% a year. The top line is still expanding, the first sign the business is still in demand.
Volatile. Profit went from $10.5B in FY2016 to $16.0B in FY2025, about 4.8% a year. The business is keeping more profit over time, not less.
operating margin went from 20.6% to 24.3% (volatile); net margin went from 16.1% to 19.0% (volatile). Margins have held roughly steady, so the business keeps about the same slice of each dollar.
Volatile. Free cash flow went from $12.1B in FY2016 to $14.0B in FY2025, about 1.6% a year. The profit is showing up as real cash, which is what you want to see.
Over the last 10 years the company returned about $68.5B through buybacks and $82.5B through dividends to shareholders. Whether that cash was spent well depends on the price paid for the stock, which this section does not judge. It shows the choices, not a verdict.
Derived from the annual figures this company reported to the SEC. What is described already happened; it is not a forecast.
Not reported here. We cannot measure this for Procter & Gamble from its filings: it does not separately report the direct cost of its product, which is an accounting choice, not a sign of weak pricing. Its competitive advantages are covered below.
Widening. Procter & Gamble's sales grew about 2.9% a year, and its operating margin went from 20.6% to 24.3% over the same period.
Variable. Procter & Gamble's operating margin swung widely over the last 9 years (from 20.6% to 24.3%).
The Investment Case describes Procter & Gamble's competitive advantages, and the risks that could erode them.
These are the quality measures the financial statements support. Several others, such as brand strength and customer concentration, need human judgment and are not measured automatically.
Historically, the company has used a mix of reinvestment, buybacks, and dividends.
On average, capital spending used about 20% of operating cash flow across 10 fiscal years (FY2016-FY2025) - a moderate share of the cash the business generated went back into it.
Reported share repurchases in 10 of the 10 fiscal years shown, totaling about $68.5B (FY2016-FY2025). The reported share count fell about 12% from FY2016 to FY2025.
Paid a per-share dividend in each of the 10 fiscal years shown (FY2016-FY2025). In FY2025, dividends paid totaled about $9.9B.
The total debt balance rose over the window: about $33.4B in FY2016 vs about $39.9B in FY2025. This describes the balance's direction, not repayments.
As of FY2025, held about $9.6B in cash and equivalents vs about $39.9B of total debt - more total debt than cash at that date.
Derived from annual figures this company reported to the SEC (EDGAR XBRL company facts). Descriptive history only: not a forecast, not a rating, not investment advice.
What has varied in Procter & Gamble Company (The)'s past filings, and what to keep an eye on. Descriptive, not a forecast and not a rating.
Procter & Gamble is a defensive consumer staples compounder, and the long-term question is whether steady pricing power and brand strength keep funding reliable cash returns.
Educational analysis from public filings. This is not a recommendation to buy or sell any security.
See all our Investment Cases on Stock Watch →
Compare its behavior on the Stock Screener →
Sources: Procter & Gamble 10-K (SEC EDGAR), Procter & Gamble Investor Relations · Last reviewed June 2026
Market Cap, Dividend Yield, Valuation
Procter & Gamble is a defensive consumer staples compounder, and the long-term question is whether steady pricing power and brand strength keep funding reliable cash returns.
A portfolio of trusted everyday brands plus global scale gives the company shelf space and pricing power that are difficult to dislodge.
Everyday household demand is relatively stable across economic cycles, which steadies sales.
Growth is inherently modest because the product categories are mature.
Private label (store brand) competition intensifies during downturns as consumers trade down on everyday items. Revenue growth is inherently limited by the nature of the product categories; detergent demand doesn't surge.
The market often assigns quality and defensive businesses a premium, which can limit future returns if growth stays modest. Weigh valuation using the company's own filings rather than a third-party estimate.
Organic sales growth and the balance between pricing and volume.
Educational content only. Market data is delayed and is not financial advice. Always do your own research and consult a licensed professional before investing.